tiprankstipranks
Trending News
More News >
EQL Pharma AB (DE:7JK)
:7JK
Germany Market

EQL Pharma AB (7JK) Income Statement

Compare
0 Followers

EQL Pharma AB Income Statement

Last quarter (Q1 2023), EQL Pharma AB's total revenue was $―, a decrease of ― from the same quarter last year. In Q1, EQL Pharma AB's net income was $7.39M. See EQL Pharma AB’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 22Mar 21Mar 20Mar 19Dec 16
Total Revenue
$ ―$ ―$ ―$ ―$ ―
Gross Profit
$ 95.73M$ 68.83M$ 36.82M$ 27.66M$ 19.72M
Operating Expenses
$ ―$ ―$ ―$ ―$ ―
Depreciation and Amortization
$ ―$ 17.27M$ 4.13M$ 4.80M$ 1.56M
EBITDA
$ 38.84M$ 28.72M$ 7.29M$ 3.37M$ 5.11M
Operating Income
$ 38.56M$ 11.44M$ 3.15M$ -1.42M$ 3.55M
Other Income/Expenses
$ ―$ ―$ ―$ ―$ ―
Pretax Income
$ ―$ ―$ ―$ ―$ ―
Net Income
$ 31.55M$ 10.38M$ 2.71M$ -1.51M$ 3.54M
Per Share Metrics
Basic EPS
$ ―$ ―$ ―$ ―$ ―
Diluted EPS
$ ―$ ―$ ―$ ―$ ―
Weighted Average Shares Outstanding
Weighted Average Shares Outstanding (Diluted)
Currency in USD

EQL Pharma AB Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis